ArticleCureus2025
A Case Report: Ertapenem-Induced Encephalopathy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a 46-year-old patient who developed acute psychotic and neurological symptoms associated with the use of intravenous ertapenem, a carbapenem antibiotic. He was hospitalized following a road traffic accident where he sustained an open fracture over the right lower limb requiring intravenous antibiotics. He started to exhibit hallucinations, odd beliefs and twitching movements two weeks after the initiation of ertapenem. Other organic causes for this acute change in behaviour were ruled out. His symptoms continued despite the use of antipsychotics but quickly resolved within three days of the withdrawal of ertapenem. Antibiotic-induced encephalopathy, which can manifest as neurological or psychiatric symptoms, is uncommon but clinically significant. Among these, carbapenems have been occasionally associated with encephalopathy through GABAergic inhibition. This case highlights the importance of recognizing ertapenem-induced neuropsychiatric complications even in patients without conventional risk factors, underscoring the need for vigilance when evaluating acute behavioural changes during antibiotic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.